Name: Retina World Congress 2025
Start: 2025-05-08
End: 2025-05-11
Location: Fort Lauderdale Marriott Harbor Beach Resort & Spa

OVERVIEW

Retina World Congress 2025 is organized by Healio LIVE and will be held from May 08 - 11, 2025 at Fort Lauderdale Marriott Harbor Beach Resort & Spa, Fort Lauderdale, Florida, United States of America.

Description:
As one of the largest retina meetings in the world, Retina World Congress is leading the advancement of science in retina. Its annual meeting brings together retina specialists from every continent to achieve a global scientific and clinical exchange in retinal health. It features world-class education to improve patient outcomes and unique interaction with your colleagues from all over the world.

Join us for world-class education and networking that improves patient care

FACULTY – Learn global developments from 165 internationally-recognized experts who will share innovative clinical expertise, improving the outcome of patient care.
EDUCATION – Earn up to 25.75 CME credits while gaining cutting-edge advances in medical retina, surgery, imaging, technology and complications.
ATTENDEES – Attend one of the largest retina meetings in the world with 1,000 physicians, healthcare providers and industry participants from the U.S., 50+ countries and 50+ retina societies.
NETWORKING – Take advantage of interactive opportunities including case discussions, peer research, industry exhibits and an evening reception.
ENVIRONMENT – Unwind with faculty and colleagues over a long weekend in a relaxing atmosphere with beautiful weather.

Program Summary
Retina World Congress is a non-profit organization dedicated to uniting international professionals to foster dialogue and to generate consensus about retinal diseases, emerging technologies and treatments, best practices and clinical research. The belief is that we can foster more collaboration between national and regional retinal societies, providing a single focal point of information exchange for the global retina community. Our annual meeting offers attendees an extraordinary program created by and for retina specialists from around the globe and successfully brings together 100+ faculty and hundreds of attendees from 35+ U.S. states, 50+ countries and 50+ international retina societies.

Learning Objectives: General Sessions
Upon completion of this activity, attendees will have better knowledge of the following subject matters:

Explore diagnostic and treatment related practices and procedures that can improve the overall management of infectious, non-infectious, and drug-induced uveitis.
Examine case presentations relevant to the medical and surgical management of uveitis.
Assess macular surgery procedures and techniques that can optimize the management of macular hole, myopic traction maculopathy, and epiretinal membrane.
Examine challenging medical and surgical case presentations in patients with retinal diseases and their appropriate management.
Detail timely trends in retina practice pertaining to diversity, gender, education, and the safety of pharmacotherapy.
Interpret clinical findings from abstract presentations relevant to the medical and surgical management of retinal diseases and disorders.
Identify new advances in retina surgical technology and instrumentation, including the use of robotics, simulators, and 3D surgery.
Describe innovative approaches that can optimize secondary IOL implantation.
Assess novel management strategies, techniques, and technology that can improve outcomes in retinal detachment surgery.
Assess case presentations pertaining to the surgical management of pediatric patients with inherited and non-inherited retinal diseases and disorders.
Explore the use of gene and cell therapy in the management of inherited, as well as non-inherited retinal diseases.
Recognize new advances in the management of neovascular age-related macular degeneration (nAMD).
Examine new evidence regarding the treatment and tracking of dry age-related macular degeneration (AMD), and geographic atrophy (GA).
Describe the latest clinical trial data, patient outcomes, and emerging medical treatments for diabetic macular edema (DME) and diabetic retinopathy (DR).
Detail the use of vitrectomy and other surgical advances in the treatment of diabetic retinopathy (DR).
Examine reconstructive and surgical techniques used in trauma and proliferative vitreoretinopathy surgery.
Recognize challenges in the treatment of retinal disorders including the management of secondary glaucoma, ocular hypotony, macular detachment, keratoprosthesis implantation, scone dystrophy, endophthalmitis, and poor visibility during vitreoretinal surgery.
Describe current controversies in medical retina including the role of biosimilars, the use of gene therapy, and the treatment of geographic atrophy.
Analyze new developments in ocular oncology, along with their appropriate diagnosis and management.
Evaluate new imaging and artificial intelligence modalities that can improve retinal disease detection and better assess patient responses to therapy.
Review late breaking evidence and clinical trial results pertinent to the management of retinal diseases and disorders.